The Clinical Impact of a Gene Expression Signature That Differentiates Benign Nevi from Malignant Melanoma

被引：0
|
作者：
Rock, C.
Moyes, K.
Warf, M. B.
Leachman, S.
Clarke, L. E.
机构：
[1] Myriad Genet Labs Inc, Salt Lake City, UT USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
567
引用
收藏
页码：141A / 141A
页数：1
相关论文
共 50 条
  • [31] BENIGN MELANOCYTIC NEVI AS A RISK FACTOR FOR MALIGNANT-MELANOMA
    SWERDLOW, AJ
    ENGLISH, J
    MACKIE, RM
    ODOHERTY, CJ
    HUNTER, JAA
    CLARK, J
    HOLE, DJ
    BRITISH MEDICAL JOURNAL, 1986, 292 (6535): : 1555 - 1559
  • [32] Tissue counter analysis of benign common nevi and malignant melanoma
    Wiltgen, M
    Gerger, A
    Smolle, J
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2003, 69 (01) : 17 - 28
  • [33] Melanoma Gene Expression Markers for Surveillance of Epidermolysis Bullosa Nevi Malignant Transformation
    Ahn, Ji Won
    Johnson, Katherine
    Kohen, Laurie L.
    Chaffins, Marsha L.
    Shwayder, Tor
    JAMA DERMATOLOGY, 2016, 152 (05) : 584 - 586
  • [34] BCL-2 PROTEIN EXPRESSION IN CUTANEOUS MALIGNANT-MELANOMA AND BENIGN MELANOCYTIC NEVI
    CERRONI, L
    SOYER, HP
    KERL, H
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1995, 17 (01) : 7 - 11
  • [35] Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases
    Boyd, Alan S.
    Shakhtour, Bashar
    Shyr, Yu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (05) : 750 - 754
  • [36] Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi
    Sand, Michael
    Skrygan, Marina
    Sand, Daniel
    Georgas, Dimitrios
    Gambichler, Thilo
    Hahn, Stephan A.
    Altmeyer, Peter
    Bechara, Falk G.
    CELL AND TISSUE RESEARCH, 2013, 351 (01) : 85 - 98
  • [37] Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi
    Michael Sand
    Marina Skrygan
    Daniel Sand
    Dimitrios Georgas
    Thilo Gambichler
    Stephan A. Hahn
    Peter Altmeyer
    Falk G. Bechara
    Cell and Tissue Research, 2013, 351 : 85 - 98
  • [38] High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi
    Chin, Szu-Ying
    Wu, Pei-Ru
    Shih, Yi-Hsien
    Yeh, Chung-Min
    Lee, Woan-Ruoh
    Shen, Shing-Chuan
    Yeh, Kun-Tu
    Jiang, Ming-Chung
    Tseng, Jonathan Te-Peng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1393 - 1401
  • [39] The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi
    Sand, Michael
    Skrygan, Marina
    Georgas, Dimitrios
    Sand, Daniel
    Gambichler, Thilo
    Altmeyer, Peter
    Bechara, Falk G.
    CELL AND TISSUE RESEARCH, 2012, 350 (01) : 119 - 126
  • [40] miRna Machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi
    Sand, M.
    Georgas, D.
    Kirschke, J.
    Skrygan, M.
    Gambichler, T.
    Altmeyer, P.
    Bechara, F. G.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 869 - 869
12345